Antimicrobial usage among hospitalized children in Latvia: a neonatal and pediatric antimicrobial point prevalence survey
Related Experiment Video
Updated: Apr 22, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Inese Sviestina1, Dzintars Mozgis2
1University Children's Hospital, Riga, Latvia; Faculty of Pharmacy, Riga Stradins University, Riga, Latvia.
Insights
This study analyzed antibiotic prescribing in Latvian hospitals, finding high use of certain cephalosporins and parenteral antibiotics in children. Improvements are needed in antibiotic guidelines and prophylaxis duration.
Area of Science:
- Pediatric Infectious Diseases
- Antimicrobial Stewardship
- Hospital Pharmacy
Background:
- The Antibiotic Resistance and Prescribing in European Children (ARPEC) Project aimed to assess antimicrobial use in pediatric populations.
- Understanding current prescribing patterns is crucial for developing targeted quality improvement strategies.
Purpose of the Study:
- To analyze pediatric and neonatal antimicrobial prescribing patterns in Latvian hospitals.
- To identify areas for quality improvement in pediatric antibiotic use.
Main Methods:
- A one-day, cross-sectional point prevalence survey was conducted in 10 Latvian hospitals in November 2012.
- All inpatient pediatric and neonatal beds were included, identifying children on antimicrobial treatment.
Main Results:
- 549 patients were included; 39% of pediatric and 21% of neonatal patients received antimicrobials.
- Third-generation cephalosporins were most prescribed for pediatric patients; benzylpenicillin and gentamicin for neonates.
- Lower respiratory tract infections were the most common indication; parenteral administration and prolonged surgical prophylaxis were frequent.
Conclusions:
- High use of third-generation cephalosporins and parenteral antibiotics requires attention.
- Prolonged surgical prophylaxis and lack of local antibiotic guidelines are areas for improvement.
- Targeted interventions are needed to optimize pediatric antimicrobial prescribing in Latvia.
Background And Objective:
The point prevalence survey was conducted as part of the Antibiotic Resistance and Prescribing in European Children (ARPEC) Project. The study aimed at analyzing pediatric and neonatal antimicrobial prescribing patterns in Latvian hospitals, to identify targets for quality improvement.
Materials And Methods:
A one day cross-sectional point prevalence survey on antibiotic use in hospitalized children was conducted in November 2012 in 10 Latvian hospitals, using a previously validated and standardized method. The survey included all inpatient pediatric and neonatal beds and identified all children receiving an antimicrobial treatment on the day of survey.
Results:
Overall 549 patients were included in the study; 167 (39%) patients admitted to pediatric wards and 25 (21%) patients admitted to neonatal wards received at least one antimicrobial. Pediatric top three antibiotic groups were third-generation cephalosporins (55 prescriptions, 28%), extended spectrum penicillins (n=32, 16%) and first-generation cephalosporins (n=26, 13%). Eleven pediatric patients (85%) received surgical prophylaxis more than 1 day; 143 pediatric patients (86%) received antibiotics intravenously. Lower respiratory tract infections were the most common indications for antibiotic use both in pediatric (n=60, 35.9%) and neonatal patients (n=9, 36%). The most used antibiotics for neonatal patients were benzylpenicillin (n=12, 32%), and gentamicin (n=9, 24%).
Conclusions:
We identified a few problematic areas, which need improvement: the high use of third-generation cephalosporins for pediatric patients, prolonged surgical prophylaxis, predominant use of parenteral antibiotics and an urgent need for local antibiotic guidelines.
More Related Videos
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Antimicrobial Effectiveness
Drug Dosing: Infants and Children
Clinical Significance of Antibiotic Resistance
Pharmacokinetics in Pediatric Patients: Drug Distribution
Automated Microbial Diagnostics